OMNICELL INC (OMCL)

US68213N1090 - Common Stock

44.67  +0.56 (+1.27%)

Fundamental Rating

3

OMCL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. While OMCL seems to be doing ok healthwise, there are quite some concerns on its profitability. OMCL is not valued too expensively and it also shows a decent growth rate.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OMCL was profitable.
In the past year OMCL had a positive cash flow from operations.
Of the past 5 years OMCL 4 years were profitable.
In the past 5 years OMCL always reported a positive cash flow from operatings.

1.2 Ratios

OMCL's Return On Assets of -0.77% is fine compared to the rest of the industry. OMCL outperforms 67.91% of its industry peers.
Looking at the Return On Equity, with a value of -1.44%, OMCL is in the better half of the industry, outperforming 68.98% of the companies in the same industry.
Industry RankSector Rank
ROA -0.77%
ROE -1.44%
ROIC N/A
ROA(3y)0.99%
ROA(5y)1.94%
ROE(3y)1.86%
ROE(5y)3.23%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OMCL has a Gross Margin of 41.38%. This is in the lower half of the industry: OMCL underperforms 66.31% of its industry peers.
OMCL's Gross Margin has declined in the last couple of years.
OMCL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-1.62%

More info and screens

4

2. Health

2.1 Basic Checks

OMCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OMCL has more shares outstanding
OMCL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OMCL has remained at the same level compared to a year ago.

2.2 Solvency

There is no outstanding debt for OMCL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 4.84
Altman-Z N/A
ROIC/WACCN/A
WACC7.74%

2.3 Liquidity

OMCL has a Current Ratio of 1.05. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
OMCL's Current ratio of 1.05 is on the low side compared to the rest of the industry. OMCL is outperformed by 91.98% of its industry peers.
OMCL has a Quick Ratio of 1.05. This is a bad value and indicates that OMCL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.95, OMCL is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.95

More info and screens

4

3. Growth

3.1 Past

OMCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.13%.
The Earnings Per Share has been decreasing by -1.69% on average over the past years.
OMCL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.27%.
Measured over the past years, OMCL shows a small growth in Revenue. The Revenue has been growing by 7.82% on average per year.
EPS 1Y (TTM)-25.13%
EPS 3Y-9.06%
EPS 5Y-1.69%
EPS Q2Q%-9.68%
Revenue 1Y (TTM)-10.27%
Revenue growth 3Y8.74%
Revenue growth 5Y7.82%
Sales Q2Q%-5.44%

3.2 Future

The Earnings Per Share is expected to grow by 3.61% on average over the next years.
The Revenue is expected to grow by 10.50% on average over the next years. This is quite good.
EPS Next Y-11.4%
EPS Next 2Y-1.84%
EPS Next 3Y3.61%
EPS Next 5YN/A
Revenue Next Year-3.43%
Revenue Next 2Y0.68%
Revenue Next 3Y1.82%
Revenue Next 5Y10.5%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.24, the valuation of OMCL can be described as expensive.
Based on the Price/Earnings ratio, OMCL is valued a bit cheaper than the industry average as 75.40% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.96, OMCL is valued at the same level.
A Price/Forward Earnings ratio of 24.27 indicates a rather expensive valuation of OMCL.
Based on the Price/Forward Earnings ratio, OMCL is valued cheaply inside the industry as 81.28% of the companies are valued more expensively.
OMCL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 31.24
Fwd PE 24.27

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMCL indicates a somewhat cheap valuation: OMCL is cheaper than 70.05% of the companies listed in the same industry.
OMCL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OMCL is cheaper than 91.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.39
EV/EBITDA 32.84

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.84%
EPS Next 3Y3.61%

More info and screens

0

5. Dividend

5.1 Amount

OMCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OMNICELL INC

NASDAQ:OMCL (11/22/2024, 12:49:43 PM)

44.67

+0.56 (+1.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.05B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 31.24
Fwd PE 24.27
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.77%
ROE -1.44%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 41.38%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.05
Quick Ratio 0.95
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-25.13%
EPS 3Y-9.06%
EPS 5Y
EPS Q2Q%
EPS Next Y-11.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.27%
Revenue growth 3Y8.74%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y